Regions outside the United States

SHYCOCAN™ Prototype/Test Devices

SHYCOCAN® Prototype/Test Devices

SHYCOCAN® - Scalene Hypercharge Corona Canon air-purifier is intended to disable air and surface-borne coronaviruses

  • Scalene Hypercharge Corona Canon (SHYCOCAN®) is intended to disable certain viruses including coronaviruses, the virus associated with COVID-19.

  • It is NOT a plasma generator, ionizer, UV/Ozone disinfection, or HEPA filter.

  • The Device is a simple, portable, sensitive methodology to disable coronaviruses.

  • Can complement hand washing, sanitizing and using PPEs.

  • The negative charge-seeking guidance mechanism of the virus’ Spike Protein can be disabled and neutralized by trillions of electrons being generated per second. Device is Intended to disable virus particles in the air and on surfaces.

  • Extremely high-intensity discharge of electrons relies on precision design and geometry of the radiating surfaces in the device.

  • Our unique and innovative device intended for electron-mediated virus deactivation can be readily and cost-effectively manufactured to meet demand.

SHYCOCAN™ Retail Device

SHYCOCAN™ Retail Device

SHYCOCAN PERFORMANCE

  • 99.994% ( >4log10 ) reduction in a standard MS2 Bacteriophage decontamination assay

  • 99.963% reduction of an EPA-standard SARS-CoV-2 surrogate, in BSL-2 facilities.

  • Elimination of expectorated Influenza B viral loads, in BSL-2 facilities.

  • SARS-CoV-2 assays in enhanced BSL-3 facilities completed

  • Can be run 24/7 and operates on standard 110/240v wall outlet

  • Plug and play device with no setup required except for mounting on side wall, pedestal or table-top

  • Please refer to the SHYCOCAN FAQs for detailed information and answers to common questions as well as the Product Brief

*See Resources for Product Brief, and FAQs for detailed information and answers to common questions regarding the SHYCOCAN®. For further information and inquiries, please Contact Us.

 

Global launch of SHYCOCAN® on August 14th 2020! Launched in 6 continents simultaneously - Asia, North America, South America, Europe, Africa, Australia!